SI-BONE Inc. logo

SI-BONE Inc.

SIBN | NASDAQ
Chart Builder DCF Calculator
$18.45
+$0.36 (+1.99%)
At close: Sep 21, 2026, 4:00 PM ET
$18.54
+$0.09 (+0.49%)
After-hours: Sep 21, 2026, 7:30 PM ET

Company Profile

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.

Key Executives

Name Position
Laura A. Francis Chief Executive Officer & Director
Scott A. Yerby Senior Vice President of Engineering & Chief Technology Officer
Anshul Maheshwari COO & CFO
Anthony J. Recupero Advisor
Daniel Joseph Cher Senior Vice President of Clinical, Regulatory Affairs & Quality
Ian Bailey Vice President of Product & Marketing
Jeffrey W. Dunn Executive Chairman
Michael A. Pisetsky Chief Business & Legal Affairs Officer, Secretary and General Counsel
Nikolas F. Kerr Chief Commercial Officer
Saqib Iqbal Vice President of Financial Planning & Analysis and Investor Relations
W. Carlton Reckling Chief Medical Officer & Vice President of Medical Affairs

Latest SEC Filings

Date Type Title
Sep 03, 2026 4 Filing
Aug 26, 2026 4 Filing
Aug 26, 2026 4 Filing
Aug 21, 2026 4 Filing
Aug 21, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 05, 2026 4 Filing
View All SEC Filings
SI-BONE Inc.
SI-BONE Inc. logo
Country United States
IPO Date Oct 16, 2018
Industry Medical - Devices
Sector Healthcare
Employees 376
CEO Laura A. Francis

Contact Details

471 El Camino Real Santa Clara, California 95050 United States

Stock Details

Ticker Symbol SIBN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001459839
CUSIP Number 825704109
ISIN Number US8257041090
SIC Code 3841

© 2026 bestshares.com. All rights reserved.